Sign in with Google. Opens in new tab
ENTITY
SMARTSCORE: 3.2/5

Gossamer Bio Inc (GOSS US)

2
Analysis
Health CareUnited States
Gossamer Bio, Inc. operates as a biopharmaceutical company. The Company focuses on discovering, acquiring, and developing therapeutics in the disease areas of immunology, inflammation, and oncology. Gossamer Bio serves customers in the United States.
more
26 Nov 2024 02:18Syndicated

Gossamer Bio Inc (GOSS) - Monday, Aug 26, 2024

Gossamer Bio is developing seralutinib for PAH in Phase 3 clinical trials. Recent changes in C-suite, insider stock purchases, and partnerships...

Logo
259 Views
Share
bullishS&P 500 INDEX
09 Aug 2022 22:18

S&P 500, Nasdaq 100 Testing Key Resistance Levels; Pause Likely; Buying Biotech

$SPX is testing important resistance in the 4165-4180 area, the same resistance level we were monitoring in early June before the market tumbled 13...

Logo
395 Views
Share
No more insights
x